The Department of Family Medicine at Ohio State University is currently enrolling for a research study for Type 2 diabetics who are currently not taking any medication to treat their diabetes or are taking only one medication to treat their diabetes. This study evaluates the safety and effectiveness of a new diabetes drug, called dutogliptin, when taken in combination with Actos, to treat their diabetes. Participants will receive study-related care, study medication, lab tests, glucose monitoring supplies, and nutrition and exercise counseling at no charge. The research study will last for up to 38-42 weeks (approximately 10-12 months) and there will be eight visits to our clinic. Participants will be paid up to $900 for completing the study.
Qualified participants must:
- Be 18-85 years of age
- Currently be taking a sulfonylurea (e.g., glipizide, Glimeperide, Glyburide) for Type II Diabetes
- Have a screening HgA1c of 7% to 10%
- Currently be taking two or fewer diabetes medications or
- Have had a fasting plasma glucose result of > 126 mg/dL at least three months before screening
- Not currently in a weight loss program
If you are interested in learning more about this study, please contact Joan Allen, RN at (614) 366-6636 or by e-mail at joan.allen@osumc.edu.